Walgreens in early talks to separate Boots chain, Bloomberg says

Walgreens Boots Alliance has revived talks about ways to separate its U.K.-based Boots drugstore chain, which could be valued at about $8.8B in any deal, Vinicy Chan, David Hellier and Swetha Gopinath of Bloomberg report, citing people with knowledge of the matter. The company is studying a London initial public offering as one possibility, the people said. Any process would only start next year at the earliest, they added.